Skip to main content
Fig. 5 | BMC Medical Genetics

Fig. 5

From: Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3

Fig. 5

EGR3 was a target of miRNA-210. a A binding site at 3′-UTR of EGR3 was predicted on miRNA-210 by Target Scan. b-d Silencing of miRNA-210 increased the mRNA and protein expression of EGR3. * P < 0.05 compared with the Blank group. e The relative fluorescence unit was significantly decreased in the mimic + wild group. * P < 0.05 compared with the mimic + mutation group. All experiments were performed in triplicate, and data were expressed as mean ± standard deviation (SD)

Back to article page